12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

Celgene, LLS deal

Celgene and the Leukemia & Lymphoma Society partnered to identify and fund blood cancer research projects under LLS's Targets, Leads & Candidates Program (TLCP). Celgene is the first company to partner with LLS under the...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >